These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11795359)
1. Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium. Hendrix SL; McNeeley SG Ann N Y Acad Sci; 2001 Dec; 949():243-50. PubMed ID: 11795359 [TBL] [Abstract][Full Text] [Related]
2. Urogenital effects of selective estrogen receptor modulators: a systematic review. Albertazzi P; Sharma S Climacteric; 2005 Sep; 8(3):214-20. PubMed ID: 16390753 [TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Jordan VC; Gapstur S; Morrow M J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060 [TBL] [Abstract][Full Text] [Related]
4. Use of SERMs for treatment in postmenopausal women. Pinkerton JV; Thomas S J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794 [TBL] [Abstract][Full Text] [Related]
5. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. Rohatgi N; Blau R; Lower EE J Womens Health Gend Based Med; 2002 Apr; 11(3):291-301. PubMed ID: 11988138 [TBL] [Abstract][Full Text] [Related]
7. [The effects of tamoxifen on the female genital tract]. Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536 [TBL] [Abstract][Full Text] [Related]
8. What would be the properties of an ideal SERM? Anthony M; Williams JK; Dunn BK Ann N Y Acad Sci; 2001 Dec; 949():261-78. PubMed ID: 11795362 [TBL] [Abstract][Full Text] [Related]
9. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development. Pinkerton JV; Goldstein SR Menopause; 2010; 17(3):642-53. PubMed ID: 20107426 [TBL] [Abstract][Full Text] [Related]
10. The selective estrogen receptor modulators in breast cancer prevention. Li F; Dou J; Wei L; Li S; Liu J Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504 [TBL] [Abstract][Full Text] [Related]
11. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene. Lee WL; Cheng MH; Chao HT; Wang PH Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579 [TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators. Haskell SG South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186 [TBL] [Abstract][Full Text] [Related]
19. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer. Baumann CK; Castiglione-Gertsch M Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839 [TBL] [Abstract][Full Text] [Related]